-+ 0.00%
-+ 0.00%
-+ 0.00%

TELOMIR PHARMACEUTICALS - TO USE PROCEEDS FOR CLINICAL DEVELOPMENT OF TELOMIR-ZN AND PHASE 1/2 TNBC PROGRAM

Reuters·10/06/2026 12:08:11